Course program

The Annual Meeting of the Finnish Stem Cell Network, 31.8.-1.9.2017, Kuopio
Program updated 21.8.2017

Thursday, August 31
13.00-14.00 Arrival, check in & lunch            
SESSION I: Chairs Sarka Lehtonen & Riikka Martikainen  
14.00-15.00 Keynote lecture by Frank Edenhofer, Innsbruck: Novel pathways of neural reprogramming generate autologous stem cells for biomedical applications       
15.00-15.20 Tiina Joki, Tampere: Human neural 3D cultures: pluripotent stem cell derived neural cells in hydrogels
15.20-15.40 Riikka Äänismaa, Helsinki: iPSC-derived neuronal cells as models for epilepsy in spinocerebellar ataxias MIRAS and IOSCA
15.40-16.00 Markus Sainio, Helsinki: Personalized single motoneuron transcriptomics in axon degeneration diseases
16.00-17.00          Coffee, posters and sponsor exhibition
SESSION II: Chair Ras Trokovic
Jussi Koivumäki, Kuopio: Structural immaturity limits the translational potential of human iPSC-derived cardiomyocytes
17.20-17.40 Jere Weltner, Helsinki: CRISPRa mediated reprogramming of primary human skin cells into iPSC
17.40-18.00 Jan Ghyssaert, ThermoFisher: Stem Cell Products for modern applications such as genome editing
18.00-18.30 the Annual meeting of the Finnish Stem Cell Network                                      
18.00-20.00 Outdoors activity & smoke sauna
20 - Dinner & evening program at Jätkänkämppä
Friday, September 1
SESSION III: Chair Merja Jaronen


Paul Vulto, Mimetas: Organ-on-a-Chip: The new paradigm in physiologically relevant cell culture
09.20-09.40 Seppo Vainio, Oulu: Stem Cell Based Organoid Disease Models via Mammalian Renal Tissue Engineering Tool Box
09.40-10.00 Satu Kuure, Helsinki: GDNF controls ureter length by regulating collecting duct progenitor expansion
10.00-10.20 Thorsten Decker, Milteney: GMP-compliant iPSC expansion and differentiation on the CliniMACS® Prodigy platform
10.20-10.40          Coffee and sponsor exhibition
SESSION IV: Chair Meike Keuters
10.40-11.00 Li-li Cui, Kuopio: Integrin Q4 overexpression on MSCs enhances transmigration and reduces cerebral embolism after intracarotid injection
11.00-11.20 Tanja Paavilainen, Tampere: Production and characterization of human iPSC-derived reactive astrocyte phenotype
11.20-11.40 Minna Oksanen, Kuopio: Human iPSC-derived Alzheimer’s disease astrocytes recapitulate disease-related phenotypes
11.40-12.00 Marina Wiklander, Merck: 3D Neural Stem Cell Models of Alzheimer's Disease
12.00-13.00          Lunch
SESSION V: Chair Jonna Saarimäki-Vire
13.00-13.20 Hazem Ibrahim, Helsinki: Modelling of RFX6 associated neonatal diabetes using CRISPR/Cas9 edited patient iPSCs
13.20-13.40 Rosa Woldegebriel, Helsinki: Motor neuron modeling of defective mRNA export factor GANP in Charcot-Marie Tooth neuropathy
13.40-14.00 Sanna Ryytty, Kuopio: Distinct metabolic changes in iPS-derived cardiomyocytes with m.3243A>G mutation
14.00-14.10 Closing and departure